Liang M H, Socher S A, Larson M G, Schur P H
Department of Rheumatology/Immunology, Harvard Medical School, Brighamand Women's Hospital, Boston, Massachusetts.
Arthritis Rheum. 1989 Sep;32(9):1107-18. doi: 10.1002/anr.1780320909.
Six systems for defining and evaluating disease activity in patients with systemic lupus erythematosus (SLE) (the Ropes system, the National Institutes of Health [NIH] system, the New York Hospital for Special Surgery system, the British Isles Lupus Assessment Group [BILAG] scale, the University of Toronto SLE Disease Activity Index [SLE-DAI], and the Systemic Lupus Activity Measure [SLAM]) were tested on 25 SLE patients who were selected to represent a range of disease activity. The patients were evaluated independently by 2 physicians on 2 occasions approximately 1 month apart. Differences between patients demonstrated the largest source of variation in scores, accounting for 56-84% of the total variance, depending on the instrument. Differences between physicians (i.e., error) showed the next largest variation, 11-28% of the total variance, and differences between visits made up 5-16% of the total. The BILAG, SLE-DAI, and SLAM had the best inter-visit and inter-rater reliability. Convergent validity was shown by the strong correlations of scores among the different instruments (r = 0.81-0.97). All instruments correlated highly with the physicians' clinical impression of disease but less well with their evaluation of disease severity. The number of American Rheumatism Association criteria for SLE that were met by the patients correlated poorly with the physicians' global evaluation and with the scores of the instruments. The patients' self-reported disease activity scores correlated highly with the physicians' assessments of disease activity (r = 0.85-0.91), and the mean values from self-reports and from physicians' assessments were nearly equal. In contrast, severity scores correlated less well between self-reports and physician assessments (r = 0.49-0.69), and mean self-reported severity values were lower than the means from physicians. The BILAG, SLE-DAI, and SLAM systems appear to have better psychometric properties than the others for clinical research.
针对25名系统性红斑狼疮(SLE)患者测试了六种用于定义和评估疾病活动的系统(罗普斯系统、美国国立卫生研究院 [NIH] 系统、纽约特种外科医院系统、英伦三岛狼疮评估组 [BILAG] 量表、多伦多大学SLE疾病活动指数 [SLE-DAI] 以及系统性狼疮活动测量 [SLAM]),这些患者被挑选出来以代表不同程度的疾病活动。由两名医生在大约相隔1个月的两个时间点对患者进行独立评估。患者之间的差异显示出得分变异的最大来源,占总变异的56 - 84%,具体取决于所使用的工具。医生之间的差异(即误差)显示出第二大变异,占总变异的11 - 28%,而不同评估时间之间的差异占总变异的5 - 16%。BILAG、SLE-DAI和SLAM在不同评估时间之间以及评估者之间具有最佳的可靠性。不同工具之间得分的强相关性(r = 0.81 - 0.97)表明了收敛效度。所有工具与医生对疾病的临床印象高度相关,但与他们对疾病严重程度的评估相关性较差。患者符合美国风湿病学会SLE标准的数量与医生的整体评估以及工具得分相关性较差。患者自我报告的疾病活动得分与医生对疾病活动的评估高度相关(r = 0.85 - 0.91),自我报告和医生评估的平均值几乎相等。相比之下,自我报告和医生评估之间的严重程度得分相关性较差(r = 0.49 - 0.69),自我报告的严重程度平均值低于医生评估的平均值。对于临床研究而言,BILAG、SLE-DAI和SLAM系统似乎比其他系统具有更好的心理测量特性。